Pediatrics

Latest News

FDA Approves First Pediatric Indication for Blockbuster Eylea
FDA Approves First Pediatric Indication for Blockbuster Eylea

February 9th 2023

Eylea now also treats retinopathy of prematurity, a leading cause of childhood blindness worldwide.

FDA Accepts BLA for RSV Prevention in Infants
FDA Accepts BLA for RSV Prevention in Infants

January 5th 2023

Wegovy Approved for Teens; Supply May be Delayed
Wegovy Approved for Teens; Supply May be Delayed

January 4th 2023

AbbVie Submits sNDA for Linzess for Children and Adolescents
AbbVie Submits sNDA for Linzess for Children and Adolescents

December 17th 2022

FDA Grants Six Months Pediatric Exclusivity for Eylea
FDA Grants Six Months Pediatric Exclusivity for Eylea

October 21st 2022

More News

© 2023 MJH Life Sciences

All rights reserved.